Literature DB >> 27742663

Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.

Juan Xu, ZiShan Wang, Shengli Li, Juan Chen, Jinwen Zhang, Chunjie Jiang, Zheng Zhao, Jing Li, Yongsheng Li, Xia Li.   

Abstract

Although systematic genomic studies have identified a broad spectrum of non-coding RNAs (ncRNAs) that are involved in breast cancer, our understanding of the epigenetic dysregulation of those ncRNAs remains limited. Here, we systematically analysed the epigenetic alterations of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in two breast cancer subtypes (luminal and basal). Widespread epigenetic alterations of miRNAs and lncRNAs were observed in both cancer subtypes. In contrast to protein-coding genes, the majority of epigenetically dysregulated ncRNAs were shared between subtypes, but a subset of transcriptomic and corresponding epigenetic changes occurred in a subtype-specific manner. In addition, our findings suggested that various types of epi-modifications might synergistically modulate ncRNA transcription. Our observations further highlighted the complementary dysregulation of epi-modifications, particularly of miRNA members within the same family, which produced the same directed alterations as a result of diverse epi-modifications. Functional enrichment analysis revealed that epigenetically dysregulated ncRNAs were significantly involved in several hallmarks of cancers. Finally, our analysis of epigenetic modification-mediated miRNA regulatory networks revealed that cancer progression was associated with specific miRNA-gene modules in two subtypes. This study enhances understanding of the aberrant epigenetic patterns of ncRNA expression and provides new insights into the functions of ncRNAs in breast cancer subtypes.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  breast cancer subtypes; epigenetics; miRNA modules; non-coding RNAs; oncogentic pathways

Mesh:

Substances:

Year:  2018        PMID: 27742663     DOI: 10.1093/bib/bbw099

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  7 in total

1.  LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations.

Authors:  Yongsheng Li; Lili Li; Zishan Wang; Tao Pan; Nidhi Sahni; Xiyun Jin; Guangjuan Wang; Junyi Li; Xiangyi Zheng; Yunpeng Zhang; Juan Xu; Song Yi; Xia Li
Journal:  Nucleic Acids Res       Date:  2018-02-16       Impact factor: 16.971

2.  Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers.

Authors:  Ning Zhao; Maozu Guo; Chunlong Zhang; Chunyu Wang; Kuanquan Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-27

3.  Long Non-Coding RNA NEAT1 Promotes the Proliferation, Migration, and Metastasis of Human Breast-Cancer Cells by Inhibiting miR-146b-5p Expression.

Authors:  Songming Li; Junwen Hao; Yun Hong; Junhao Mai; Weijun Huang
Journal:  Cancer Manag Res       Date:  2020-07-21       Impact factor: 3.989

4.  Blocking circ_0000520 Suppressed Breast Cancer Cell Growth, Migration and Invasion Partially via miR-1296/SP1 Axis Both in vitro and in vivo.

Authors:  Hongliang Zang; Yuhui Li; Xue Zhang; Guomin Huang
Journal:  Cancer Manag Res       Date:  2020-08-25       Impact factor: 3.989

5.  Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.

Authors:  Xianfu Sun; Tao Huang; Chengjuan Zhang; Shengze Zhang; Yingjie Wang; Qiang Zhang; Zhenzhen Liu
Journal:  Cell Cycle       Date:  2019-06-29       Impact factor: 5.173

6.  Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

Authors:  Hani Choudhry; Mazin A Zamzami; Ziad Omran; Wei Wu; Marc Mousli; Christian Bronner; Mahmoud Alhosin
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

7.  HFS-SLPEE: A Novel Hierarchical Feature Selection and Second Learning Probability Error Ensemble Model for Precision Cancer Diagnosis.

Authors:  Yajie Meng; Min Jin
Journal:  Front Cell Dev Biol       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.